Login Register
icon_bulk_orderBulk order Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CXCL10

CXCL10

Brief Information

Name:C-X-C motif chemokine ligand 10
Target Synonym:Protein 10 From Interferon (Gamma)-Induced Cell Line,CXCL10,INP10,SCYB10,C-X-C motif chemokine 10,10 kDa interferon gamma-induced protein,IP-10,C-X-C Motif Chemokine Ligand 10,Small Inducible Cytokine Subfamily B (Cys-X-Cys), Member 10,Chemokine (C-X-C Motif) Ligand 10,Small-Inducible Cytokine B10,Chemokine CXCL10,Interferon-Inducible Cytokine IP-10,Gamma IP10,Gamma-IP10,GIP-10,IFI10,Crg-2,Mob-1,C7
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
Cat. No. Species Product Description Structure Purity Feature
CX0-H51H1 Human Human CXCL10 / IP-10 Protein, His Tag
CX0-H51H1-structure

Synonym Name

C-X-C motif chemokine 10,10 kDa interferon gamma-induced protein,Gamma-IP10,IP-10,Small-inducible cytokine B10,CXCL10(1-73),CXCL10,INP10, SCYB10

Background

C-X-C Motif Chemokine Ligand 10 (CXCL10) is a pro-inflammatory chemokine secreted by a wide spectrum of cells. It is involved in multiple mechanisms and reported to have pleiotropic effects, including immune cell migration and attraction to inflammation sites, angiogenesis, and cancer cell growth. CXCL10 is produced by pancreatic islet cells upon inflammatory stress and is specifically recognized by C-X-C Motif Chemokine Receptor 3 (CXCR3) which is expressed by activated T-lymphocytes and other immune cells.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
JT-02 (JYANT Technologies) JT-02 Phase 2 Clinical Jyant Technologies Inflammatory Bowel Diseases Details
Eldelumab MDX-1100; BMS-936557 Bristol-Myers Squibb Company, Medarex Details
NI-0801 Alpha-IP-10; NI-0801; α-IP-10 Novimmune Details
NG-641 NG-641; NG-aFAP; EnAd-FAP-Tac; EnAd-FAP-BiTE Phase 1 Clinical University Of Oxford, Psioxus Therapeutics Ltd Squamous Cell Carcinoma of Head and Neck; Neoplasms, Glandular and Epithelial; Neoplasm Metastasis Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message